NSEInvestor Presentation20h ago · 30 Oct 2026, 06:57 pm
Investor Presentation
Narayana Hrudayalaya Ltd. · NH
✦ AI SummaryResults
Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation for the quarter and half year ended September 30, 2026, highlighting operational and financial performance, including revenue growth, EBITDA margin, and net debt to equity ratio.
Analysis Scores
Earnings Impact8/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact9/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation
Attachments (1)
📄pdf
Download →
Narayana_30102026185651_SENHLInvestorPresentationOct_302026NHL.pdf
View document text
Date of submission: October 30, 2026
To, To,
The Secretary The Secretary
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Department of Corporate Services Exchange Plaza, Bandra Kurla Complex
Phiroze Jeejeebhoy Towers, Mumbai – 400 051
Dalal Street, Mumbai – 400 001 Scrip Code- NH
Scrip Code – 539551 (EQ), 975516 & 976418
Dear Sir/Madam,
Sub: Investor Presentation for the quarter and half year ended September 30, 2026.
With reference to the subject, please find enclosed the Investor Presentation for the quarter and half
year ended September 30, 2026
Kindly take the above information on record.
Thanking you
Yours faithfully
For Narayana Hrudayalaya Limited
Sridhar S.
Group Company Secretary, Legal & Compliance Officer
Encl.: as above
Earnings Update
Q2 FY27
Topic Slide No.
Our Footprint 03
Narayana Health at a Glance 04
Q2 FY27 Highlights 05
Index
Capex 16
Digital Initiatives 17
Narayana Health ESG Vision – “Health For All” 18
Shareholding Pattern 19
Our Footprint
(as on 1st October 2026)
United Kingdom India
Ophthalmology Centers
Hospitals/ Surgical Centers
Diagnostic Centers
Hospitals/Surgical Centers +
Delhi NCR
Urgent Treatment Centers
Barlborough Jaipur
Rochdale
Guwahati
Lincolnshire
Birmingham
Buckinghamshire Ahmedabad
Jamshedpur
Emersons Devizes Ilford Raipur Kolkata
Green
Gillingham
Shepton Mallet
Southampton Mumbai
Portsmouth
Plymouth
Davanagere
Cayman Islands Shimoga
Bengaluru
Mysore
Health City
Camana Bay
Health City
Cayman Islands
Narayana Health – At a Glance
Total Capacity Beds
6,374
Facility Details No. of Facilities Operational Beds South (India)
Hospitals - 7 | Heart Centres - 2| Clinics -15 |
Diagnostic Centre - 1
India – Hospitals and Heart Centres 21 5,624 Operational Beds - 2,159 (Hospitals) and 132 (HC)
East (India)
India - Clinics and Dialysis Centres (1) 20 0
Hospitals - 7 | Clinics - 3| Dialysis Centre - 1
Operational beds - 2,121
Cayman Islands 2 165
North (India)
Hospitals – 3
United Kingdom 13 330
Operational beds: 838
West (India)
Healthcare Facilities 56 6,119
Hospitals - 2
Operational beds - 374
(1)This includes 12 (Twelve) Integrated Care Clinics as on 30th Sep 2026.
Total Staff ~21,150
(2)Banashankari Hospital and Nagarabhavi Clinic commenced operations in the last week of
Clinical : ~ 13,100
Sep'26; operating metrics will be reflected from Q3 FY27.
Non-clinical : ~ 8,050
Key Highlights – Operational & Financial Performance (Q2 FY27)
▪ Narayana Institute of Cardiac Sciences, Bengaluru has performed :
• South India’s first Percutaneous Transcatheter Tricuspid Valve Replacement (TTVR)
• India’s first Transcatheter Tricuspid Valve Implantation (TTVI) on a 14-year-old
• 54 TAVIs and 6 hybrid percutaneous pulmonary valve implantations in Q2 FY 27
• Highest volume of cardiac surgeries cases in a single day: 38 cases.
▪ NH Mumbai successfully managed
• Complex surgical management of a newborn presented with sternal cleft, a very rare condition.
Clinical & ▪ NH RTIICS achieved:
Operational • Multidisciplinary surgery for spindle cell sarcoma of the adnexa with extensive IVC tumor thrombus
extending into the right atrium
• Robotic-assisted resection of Type B3 thymoma with phrenic nerve invasion in a patient with myasthenia
gravis.
▪ Consolidated operating revenues of ₹ 28,440 Mn in Q2 FY27, a change of +73.0% YoY and +6.0% QoQ.
▪ Consolidated EBITDA of ₹ 6,054 Mn in Q2 FY27 at a margin of 21.3%. Consolidated PAT of ₹ 3,012 Mn for
Q2 FY27 at a margin of 10.6%.
Financial ▪ Consolidated Total Borrowings less Cash & Bank Balance and Investments of ₹ 18,830 Mn as on 30th
Performance September 2026, i.e., net debt to equity ratio of 0.38 (Out of which, debt worth US $114 Mn and GBP £150
Mn are foreign currency denominated).
India Operations – Revenue (Q2 FY27)
₹ Mn
Total* Domestic
14,000
13,442
20,004 13,500
C 186
14,388 13,000
13,196 12,552
15,004 12,331
12,500 C 171
9.0% QoQ 11,863
10,004 12,000 C 156 H 13,256
11,500 H 12,381
5,004
11,000 H 11,707
4 10,500
Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27
16.7% YoY H - Hospitals C - Clinics
International YTD Gross Written Premium**
1,000 901
900 505
700 405 341
41.2% QoQ
Q2 FY26 Q1 FY27 Q2 FY27
FY26 FY27
75.7% YoY
*Total revenue is excluding ATHMA, Medha and adjusted with Inter Company eliminations 6
** Gross written premium of NH Insurance. The YTD numbers are starting from 1st April of the financial year to the reporting quarters. 6
India Hospital – Revenue Mix (Q2 FY27)
Business Mix(4,7) Specialty-Profile(4,7) Payor-Profile(4,7)
25% 33% 18%
Cardiac Sciences
Medicine and GI sciences
Owned Hospitals(1)
Oncology Domestic Walk-in patients
Operated Hospitals Renal Sciences Insured Patients (5)
Neuro Sciences
Heart Centres Schemes (6)
Orthopaedics
Clinic Business Others International patients
(1) NH owns on freehold basis and operates with the P&L responsibility (5) Insured Patients include Insurance-covered patients, corporate patients (including PSU’s on hospital tariff)
(2) NH operates the hospitals on rental/revenue sharing basis and owns the P&L responsibility (6) Schemes include CGHS, ESIS, other state government schemes
(3) Includes clinics and dialysis centres excl. NHIC (7) Percentages might not add up to 100% due to rounding off
(4) As percentage of operating revenue, excluding NHIC
India Hospitals – Operations Review (Q2 FY27)
ALOS
Average Revenue Per Patient (IP & OP) (1,2)
Days
₹ ‘000
162.6 163.4
149.4
4.3 4.3 4.3
4.8 5.1 5.2
Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27
Patient Footfalls (IP & OP)(1,3) ICU Occupied Bed Days
‘000 800 81 ‘000
700 64 67 100 96 96
662 674 80
58 57 60
Q2 FY26 Q1 FY27 Q2 FY27
Q2 FY26 Q1 FY27 Q2 FY27
Hospitals OP Clinics OP IP
(1) OP figures include day-care business. Clinics OP pertains to footfalls related to NHIC.
(2) ARPOB for the period Q2 FY27 was ₹ 19.5 Mn as against ₹ 17.5 Mn in Q2 FY26. 8
(3) Footfalls for IP correspond to Discharges. 8
India Hospitals – Cluster Split (Q2 FY27)
This considers owned/operated hospitals & heart centers in India
Southern Eastern
Bangalore Kolkata Western Northern
Peripheral Peripheral
Regions • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram
• MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • New Delhi
• HSR • Davangere • NMH • Raipur • Jaipur
• Dharwad • NSH
• Kolar
Capacity Beds 1490 800 1453 745 405 882
% of Hospital
Operating 37% 9% 26% 10% 5% 13%
Revenues
YoY Revenue
Growth 18% 10% 16% 16% -1 22 %% 12%
YoY Hospital
7% 1% 2% 6% 22%% 5%
Discharges 2%
OP ARPP(1)
6.1 4.3 4.6 4.4 4.3 5.3
(₹ ‘000) 5.0 3.7 4.5 4.1 4.3 4.6
IP ARPP
251 88 169 145 130 126
(₹ ‘000) 198.3 67.9 121.4 114.7 128.3
(1) OP ARPP includes day care. 9
India Hospitals – Profitability Snapshot (Q2 FY27)
Includes NH India Hospitals
5,0E0B0ITDA and EBITDA Margin (1) Cost Structure
4,5₹0 ‘0Mn % of Operating Revenues
Chart Title
26.8% Rental / Revenue Share (7)
4,000
2% 2% 2%
3,500 24.8% (1)
100%
26.0% (2)
23.8%
11% 10% 10%
3,000 90%
23.4% (2) 80%
2,500 22.5% (2) 17% (5) 17% 18%
2,000 60%
(1) 3,799
3,229 50% 23% (3) 23% 22%
1,500
2,903
1,000 30%
27% 28% 26%
- 0%
Q2 FY26 Q1 FY27 Q2 FY27 Q2 FY26 Q1 FY27 Q2 FY27
Doctors and Nurses(4) Consumable Expenses(5)
Other Expenses(6) Other Manpower Cost
1) Denotes EBITDA and EBITDA% of India Hospitals 5) Doctors and Nurses = Employee benefits + Professional fees to doctors
2) Denotes EBITDA% of India Hospitals and NHIC Clinics together 6) Consumable Expenses = Purchase of medical consumables, drugs and surgical equipment
3) EBITDA of NH India for Q2 FY27 stood at ₹ 3,548 Mn (24.6%) net of changes in inventories of medical consumables, drugs and surgical equipment
4) EBITDA (excluding other income) of NH India Hospitals for Q2 FY27 is 23.6%; Q1 FY27: 7) Other Expenses = Overhead expenses + All other expenses
22.3%; Q2 FY26: 22.2% 8) Effect of IND AS benefits is not considered 10
India Insurance – Key Financial Summary ₹ Mn
Financial Parameters Q2 FY27 Q2 FY26
Gross Written Premium 78 70
Reinsurance Premium -3 -3
Net Written Premium 75 67
Change
[Showing first 8,000 characters — download PDF for full document]